Deep-vein thrombosis of the upper extremities

New England Journal of Medicine

Volumn 364, Issue 9, 2011, Pages 861-869

  Kucher, Nils ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; WARFARIN;

ADULT; ARM EDEMA; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL CATHETERIZATION; CASE REPORT; CATHETER THROMBOSIS; COLLATERAL CIRCULATION; DOPPLER FLOWMETER; DRUG DOSE COMPARISON; ECHOGRAPHY; FEMALE; FUNCTIONAL DISEASE; HUMAN; LUNG EMBOLISM; NECK; PHLEBOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SHOULDER; SUBCLAVIAN VEIN; THORAX; THROMBECTOMY; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VEIN BYPASS; ARM; CENTRAL VENOUS CATHETERIZATION; FIBRINOLYTIC THERAPY; INDWELLING CATHETER; MIDDLE AGED; PRACTICE GUIDELINE; RADIOGRAPHY; REVIEW; RISK FACTOR; VASCULARIZATION; VEIN THROMBOSIS;

ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; HUMANS; MIDDLE AGED; PHLEBOGRAPHY; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; RISK FACTORS; THROMBOLYTIC THERAPY; UPPER EXTREMITY; VENOUS THROMBOSIS;

EID: 79952266818     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1008740     Document Type: Article

References (54)

1. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004;110:1605-11. (Pubitemid 39297983)
2. Muñoz FJ, Mismetti P, Poggio R, et al. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008;133: 143-8.
3. Isma N, Svensson PJ, Gottsäter A, Lindblad B. Upper extremity deep venous thrombosis in the population-based Malmö Thrombophilia Study (MATS): epidemiology, risk factors, recurrence risk, and mortality. Thromb Res 2010;125(6): e335-e338.
4. Linnemann B, Meister F, Schwonberg J, Schindewolf M, Zgouras D, Lindhoff-Last E. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis: results from the MAISTHRO registry. Thromb Haemost 2008;100:440-6.
5. Lee AY, Levine MN, Butler G, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006;24: 1404-8. (Pubitemid 46622005)
6. Anderson AJ, Krasnow SH, Boyer MW, et al. Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 1989;95:71-5. (Pubitemid 19026105)
7. Verso M, Agnelli G, Kamphuisen PW, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med 2008;3:117-22.
8. Lobo BL, Vaidean G, Broyles J, Reaves AB, Shorr RI. Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J Hosp Med 2009;4:417-22.
9. Baglin TP, Boughton BJ. Central venous thrombosis due to bolus injections of antileukaemic chemotherapy. Br J Haematol 1986;63:606-7. (Pubitemid 16033583)
10. Fabri PJ, Mirtallo JM, Ebbert ML, Kudsk KA, Powell C, Ruberg RL. Clinical effect of nonthrombotic total parenteral nutrition catheters. JPEN J Parenter Enteral Nutr 1984;8:705-7. (Pubitemid 15207448)
11. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995;13:233-8.
12. Hsieh CC, Weng HH, Huang WS, et al. Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol 2009;15:4709-14.
13. van Rooden CJ, Schippers EF, Barge RM, et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005;23:2655-60. (Pubitemid 46179454)
14. Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin 2008;58:323-46.
15. Sajid MS, Ahmed N, Desai M, Baker D, Hamilton G. Upper limb deep vein thrombosis: a literature review to stream-line the protocol for management. Acta Haematol 2007;118:10-8.
16. Aziz S, Straehley CJ, Whelan TJ Jr. Effort-related axillosubclavian vein thrombosis: a new theory of pathogenesis and a plea for direct surgical intervention. Am J Surg 1986;152:57-61. (Pubitemid 16069555)
17. Illig KA, Doyle AJ. A comprehensive review of Paget-Schroetter syndrome. J Vasc Surg 2010;51:1538-47.
18. Owens CA, Bui JT, Knuttinen MG, Gaba RC, Carrillo TC. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol 2010;21:779-87.
19. Kucher N, Tapson VF, Goldhaber SZ. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost 2005;93:494-8. (Pubitemid 40392538)
20. Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmonary embolism in patients with deep venous thrombosis: a systematic review. Am J Med 2010;123: 426-31.
21. Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Doggen CJ. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation 2008;118:1366-72.
22. Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 2004;110:566-70. (Pubitemid 39031174)
23. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000;160:761-8. (Pubitemid 30165236)
24. Elman EE, Kahn SR. The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res 2006;117: 609-14.
25. Schulman S, Lindmarker P, Holmstrom M, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006;4: 734-42.
26. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003;21:3665-75.
27. Akl EA, Kamath G, Yosuico V, et al. Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis. Cancer 2008;112:2483-92.
28. van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 2004;15:1258-62. (Pubitemid 39612630)
29. Constans J, Salmi LR, Sevestre-Pietri MA, et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008;99:202-7.
30. Merminod T, Pellicciotta S, Bounameaux H. Limited usefulness of D-dimer in suspected deep vein thrombosis of the upper extremities. Blood Coagul Fibrinolysis 2006;17:225-6.
31. Di Nisio M, Van Sluis GL, Bossuyt PM, Buller HR, Porreca E, Rutjes AW. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost 2010;8:684-92.
32. Kim H, Chung JW, Park JH, et al. Role of CT venography in the diagnosis and treatment of benign thoracic central venous obstruction. Korean J Radiol 2003;4: 146-52. (Pubitemid 38569471)
33. Baarslag HJ, Van Beek EJ, Reekers JA. Magnetic resonance venography in consecutive patients with suspected deep vein thrombosis of the upper extremity: initial experience. Acta Radiol 2004;45:38-43.
34. Kovacs MJ, Kahn SR, Rodger M, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007;5:1650-3. (Pubitemid 47091406)
35. van Dongen CJ, van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2004;4:CD001100.
36. Karabay O, Yetkin U, Onol H. Upper extremity deep vein thrombosis: clinical and treatment characteristics. J Int Med Res 2004;32:429-35. (Pubitemid 39069515)
37. Prandoni P, Bernardi E, Marchiori A, et al. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ 2004;329: 484-5. (Pubitemid 39158892)
38. Savage KJ, Wells PS, Schulz V, et al. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb Haemost 1999;82:1008-10. (Pubitemid 29419709)
39. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:Suppl:454S-545S. [Erratum, Chest 2008;134:892.]
40. Hingorani A, Ascher E, Ward M, et al. Combined upper and lower extremity deep venous thrombosis. Cardiovasc Surg 2001;9:472-7. (Pubitemid 32728010)
41. Mewissen MW, Seabrook GR, Meiss-ner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999;211:39-49. [Erratum, Radiology 1999;213:930.]
42. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis: a randomised clinical trial. Eur J Vasc Endovasc Surg 2002;24:209-14. (Pubitemid 41085793)
43. Alesh I, Kayali F, Stein PD. Catheter-directed thrombolysis (intrathrombus injection) in treatment of deep venous thrombosis: a systematic review. Catheter Cardiovasc Interv 2007;70:143-8. (Pubitemid 47036009)
44. Vik A, Holme PA, Singh K, et al. Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities. Cardiovasc Intervent Radiol 2009;32:980-7.
45. Oderich GS, Treiman GS, Schneider P, Bhirangi K. Stent placement for treatment of central and peripheral venous obstruction: a long-term multi-institutional experience. J Vasc Surg 2000;32:760-9.
46. Meier GH, Pollak JS, Rosenblatt M, Dickey KW, Gusberg RJ. Initial experience with venous stents in exertional axillarysubclavian vein thrombosis. J Vasc Surg 1996;24:974-81, discussion 81-3.
47. Urschel HC Jr, Patel AN. Paget-Schroetter syndrome therapy: failure of intravenous stents. Ann Thorac Surg 2003; 75:1693-6. (Pubitemid 36677197)
48. Lin PH, Zhou W, Dardik A, et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006; 192:782-8. (Pubitemid 44854822)
49. Plate G, Einarsson E, Ohlin P, Jensen R, Qvarfordt P, Eklöf B. Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg 1984;1: 867-76. (Pubitemid 15056084)
50. Lee JT, Karwowski JK, Harris EJ, Haukoos JS, Olcott C IV. Long-term thrombotic recurrence after nonoperative management of Paget-Schroetter syndrome. J Vasc Surg 2006;43:1236-43. (Pubitemid 43841848)
51. Urschel HC Jr, Razzuk MA. Neurovascular compression in the thoracic outlet: changing management over 50 years. Ann Surg 1998;228:609-17. (Pubitemid 30194404)
52. Schneider DB, Dimuzio PJ, Martin ND, et al. Combination treatment of venous thoracic outlet syndrome: open surgical decompression and intraoperative angioplasty. J Vasc Surg 2004;40:599-603. (Pubitemid 39311623)
53. Machleder HI. Evaluation of a new treatment strategy for Paget-Schroetter syndrome: spontaneous thrombosis of the axillary-subclavian vein. J Vasc Surg 1993;17:305-15.
54. Lee WA, Hill BB, Harris EJ Jr, Semba CP, Olcott CI. Surgical intervention is not required for all patients with subclavian vein thrombosis. J Vasc Surg 2000;32:57-67. (Pubitemid 30461154)